8-K
Current Report
Apimeds Pharmaceuticals US, Inc. Filed Acc 0001213900-26-099002
Material agreement · Executive or director change
- Item 1.01 Entry into a material definitive agreement
- Item 5.02 Departure or appointment of directors or officers
From the SEC's structured data for this filing
Loading ea0305245-8k_apimeds.htm…